CK Life Sciences International (Holdings), Inc. Financial Overview
CK Life Sciences International (Holdings), Inc.'s market cap is currently HK$8.17B. The company's EPS TTM is HK$-0.016; its P/E ratio is -29.31; CK Life Sciences International (Holdings), Inc. is scheduled to report earnings on August 12, 2025, and the estimated EPS forecast is HK$―. See an overview of income statement, balance sheet, and cash flow financials.
